Related Experiment Video
Updated: Jul 26, 2025

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.6K
A novel hybrid algorithm based on Harris Hawks for tumor feature gene selection.
Junjian Liu1, Huicong Feng2, Yifan Tang2
1Department of Statistics, Hunan Normal University College of Mathematics and Statistics, Changsha, Hunan, China.
Peerj. Computer Science
|June 22, 2023
Summary
A new three-stage hybrid gene selection method, VEH, accurately identifies key cancer genes from high-dimensional data. This approach achieves 100% classification accuracy in several cancers, outperforming existing methods.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- High-dimensional gene expression data present challenges in identifying cancer-specific genes.
- Accurate selection of informative feature genes is crucial for effective cancer classification.
Purpose of the Study:
- To propose a novel, efficient, and accurate three-stage hybrid gene selection method for cancer classification.
- To enhance the identification of key genes contributing to tumor development and progression.
Main Methods:
- A three-stage hybrid approach combining a variance filter, extremely randomized tree, and Harris Hawks optimization (VEH).
- Stage 1: Variance filter to pre-select genes based on a threshold.
- Stage 2: Extremely randomized tree for eliminating irrelevant genes.
- Stage 3: Harris Hawks algorithm for optimal feature gene subset selection.
Main Results:
- The VEH method achieved 100% classification accuracy for gastric cancer, acute lymphoblastic leukemia, and ovarian cancer.
- An average classification accuracy of 95.33% was observed across diverse cancer types.
- VEH demonstrated superior performance compared to other advanced feature selection algorithms based on multiple evaluation criteria.
Conclusions:
- The proposed VEH method is highly effective for feature gene selection in cancer classification.
- VEH offers significant advantages in accuracy and efficiency over existing methods for analyzing high-dimensional gene expression data.
- This approach holds promise for improving diagnostic and prognostic tools in oncology.

